Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects

被引:114
作者
Hindmarch, I [1 ]
Shamsi, Z [1 ]
机构
[1] Univ Surrey, Human Psychopharmacol Res Unit, Res Ctr, Guildford, Surrey, England
关键词
CNS; psychoactive effects; sedation; antihistamines;
D O I
10.1046/j.1365-2222.1999.0290s3133.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Behavioural changes are produced by any drug that enters the central nervous system. These psychoactive effects include changes in alertness, concentration, attention, memory, cognition, psychomotor accuracy, skilled performance and affect. Changes in psychological performance may affect the safety of both the individuals taking the drug and of those people coming into contact with them. The aims of psychopharmacological performance tests are to describe the nature, extent and severity of these changes and identify drugs without deleterious effects upon performance. Use of traditional antihistamines has until recently been associated with a number of undesirable side-effects, the most troublesome of which is sedation. There are two aspects to sedation. Firstly, an objectively determined one based on the results of psychometric tests from controlled trials and secondly, the subjects response to the administration of a drug. Although the second generation of antihistamines have a much more favourable therapeutic index, use of these agents has also been reported to cause varying degrees of sedation. As antihistamines are largely used by ambulant patients, a complete evaluation of sedation should be performed through standardized objective tests, shown to be sensitive to the central effects of antihistamines as well as reliable ratings of subjective experiences. An extensive review of the literature has identified a number of tests which appear to be sensitive to the central effects of antihistamines. These include tests of psychomotor performance, sensori-motor co-ordination speed, information processing, sensory skills as well as physiological measures and subjective rating scales. Using this battery of cognitive and psychomotor tests, it is evident that only a very limited number of antihistamines can claim to be virtually free of both objective and subjective sedative effects, although the second generation of antihistamines are generally less impairing than the original ones; when prescribed at their recommended doses.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 61 条
[1]  
ALFORD C, 1989, Medical Science Research, V17, P421
[2]  
[Anonymous], J EUROPEAN ARCHAEOLO
[3]  
BATEMAN DN, 1984, ASTEMIZOLE NEW NONSE, P43
[4]   EFFECTS OF 2 ANTIHISTAMINE DRUGS ON ACTUAL DRIVING PERFORMANCE [J].
BETTS, T ;
MARKMAN, D ;
DEBENHAM, S ;
MORTIBOY, D ;
MCKEVITT, T .
BRITISH MEDICAL JOURNAL, 1984, 288 (6413) :281-282
[5]   EFFECTS OF AZATADINE MALEATE ON SUBJECTIVE APPRAISAL AND PSYCHOMOTOR FUNCTIONS RELEVANT TO DRIVING PERFORMANCE [J].
BIEHL, B .
CURRENT MEDICAL RESEARCH AND OPINION, 1979, 6 (01) :62-69
[6]   STUDIES ON THE CENTRAL EFFECTS OF THE H1-ANTAGONIST, LORATADINE [J].
BRADLEY, CM ;
NICHOLSON, AN .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (04) :419-421
[7]   ACUTE AND SUBCHRONIC EFFECTS OF THE H-1-HISTAMINE RECEPTOR ANTAGONIST EBASTINE IN 10, 20 AND 30 MG DOSE, AND TRIPROLIDINE 10 MG ON CAR DRIVING PERFORMANCE [J].
BROOKHUIS, KA ;
DEVRIES, G ;
DEWAARD, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (01) :67-70
[8]   PERFORMANCE STUDIES WITH ANTIHISTAMINES [J].
CLARKE, CH ;
NICHOLSON, AN .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (01) :31-35
[9]   THE ACUTE EFFECTS OF ACRIVASTINE (BW825C), A NEW ANTIHISTAMINE, COMPARED WITH TRIPROLIDINE ON MEASURES OF CENTRAL NERVOUS-SYSTEM PERFORMANCE AND SUBJECTIVE EFFECTS [J].
COHEN, AF ;
HAMILTON, M ;
PHILIPSON, R ;
PECK, AW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :381-386
[10]   THE EFFECTS OF ACRIVASTINE (BW825C), DIPHENHYDRAMINE AND TERFENADINE IN COMBINATION WITH ALCOHOL ON HUMAN CNS PERFORMANCE [J].
COHEN, AF ;
HAMILTON, MJ ;
PECK, AW .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (03) :279-288